Skip to content
healthcare.dev

Dihydroergotamine Mesylate

NDC 68083-466, Dihydroergotamine Mesylate, injection, from Gland Pharma Limited.

Product NDC
68083-466
Status
Listed
Labeler
Gland Pharma Limited
Dosage form
INJECTION
Route
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215623
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68083-466 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIHYDROERGOTAMINE MESYLATE1 mg/mL

Pharmacologic classes

Ergotamine Derivative [EPC]; Ergotamines [CS]

Package NDCNDC-11Package
68083-466-106808304661010 AMPULE in 1 CARTON (68083-466-10) / 1 mL in 1 AMPULE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/07a9112c-8c04-4849-8cb3-9463f58731d2

Use it

Look up 68083-466 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68083-466 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68083-466. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.